Decheng Capital Global Life Sciences Fund IV, L.P. - Insider Trading & Ownership

Entity: Company
Location: C/O Maples Corporate Services Limited, Ugland House, P.O. Box 309, Grand Cayman, Cayman Islands
Summary: The estimated value of insider holdings of Decheng Capital Global Life Sciences Fund IV, L.P. is at least $175M dollars as of February 19, 2025. Decheng Capital Global Life Sciences Fund IV, L.P. is the 10%+ Owner of CG Oncology, Inc. and owns shares of CG Oncology, Inc. (CGON) stock worth about $175M.
All Insider Reports: All Insider Reports

Ownership of Decheng Capital Global Life Sciences Fund IV, L.P.

Symbol	Company	Relationship	Holdings Value	Past Year Net Change	Change %	Report Period
CGON	CG Oncology, Inc.	10%+ Owner	$175M			Jan 29, 2024
AARD	Aardvark Therapeutics, Inc.	10%+ Owner				Feb 14, 2025

Showing 1 to 2 of 2 entries

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership
Loading...

Showing 0 to 0 of 0 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.